Search Ontology:
ChEBI
L-dopa
- Term ID
- CHEBI:15765
- Synonyms
-
- (-)-3-(3,4-dihydroxyphenyl)-L-alanine
- (-)-dopa
- (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
- 3,4-Dihydroxy-L-phenylalanine
- 3,4-DIHYDROXYPHENYLALANINE
- 3-Hydroxy-L-tyrosine
- beta-(3,4-dihydroxyphenyl)-L-alanine
- beta-(3,4-dihydroxyphenyl)alanine
- Dihydroxy-L-phenylalanine
- Dopar
- L-beta-(3,4-Dihydroxyphenyl)alanine
- L-DOPA
- levodopa
- levodopum
- Definition
- An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease
- References
-
- Beilstein:6060047
- CAS:59-92-7
- COMe:MOL000169
- DrugBank:DB01235
- Drug_Central:1567
- Gmelin:365846
- HMDB:HMDB0000181
- KEGG:C00355
- KEGG:D00059
- KNApSAcK:C00001357
- LINCS:LSM-5481
- MetaCyc:L-DIHYDROXY-PHENYLALANINE
- PDBeChem:DAH_LFOH
- PMID:18690870
- PMID:22491024
- PMID:22592937
- PMID:23038403
- PMID:23127496
- PMID:23196068
- PMID:23206800
- PMID:23211937
- PMID:23357114
- PMID:23389842
- PMID:23389938
- PMID:23390548
- PMID:29438107
- PMID:8301021
- Reaxys:2215169
- Wikipedia:L-DOPA
- Wikipedia:Levodopa
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from L-dopa
Phenotype where environments contain L-dopa
Phenotype modified by environments containing L-dopa
Phenotype affecting L-dopa
Human Disease Model